Discover insightful articles on health, wellness, and the habits that support a longer, stronger life.
Showing 13 to 24 of 38 articles
Landmark Validation of Human Glymphatic ActivityA significant milestone in geroscience and brain health research was achieved in January 2026 with the publicati...
The NAD+ Supplementation Debate Gets a Clinical Verdict For over a decade, the longevity and metabolic health sectors have operated under significant uncertaint...
The Shift Toward Oral, Brain-Penetrant Inflammation Modulation As geroscience advances past the initial wave of senolytic clearance and fibrosis inhibition, the...
Breaking News: Circadian Architecture Emerges as Critical Determinant of Biological Age As of late May 2026, a wave of new longitudinal research is reshaping th...
From Chronological to Cellular: The Rise of Immune Aging Clocks The landscape of biological age estimation has undergone a fundamental recalibration this spring...
The Dont Die Blueprint protocol that is free and available for everyone online to follow the perfect human diet. Review its research ground and discuss the viability for most people.
Oral Senolytics Step Out of the Lab: Phase II Trial Shows Fisetin Mitigates Physical Impairment The landscape of geroscience is undergoing a structural shift, m...
A Precise Pivot in Longevity Research As of mid-May 2026, the geroscience landscape is undergoing a quiet but decisive transition. While earlier phases of longe...
From Cellular Clearance to Tissue Protection For years, the geroscience community has operated under a straightforward therapeutic premise: if aging cells drive...
The 2026 Paradigm Shift: From Broad Action to Molecular Fidelity As the geroscience field enters mid-2026, a distinct evolution is reshaping how researchers app...
Beyond HbA1c: How Glucose Variability Accelerates Vascular Aging For years, metabolic health assessments have leaned heavily on static metrics like hemoglobin A...
The Muscle Paradox: GLP-1 Therapy, Lean Mass Loss, and Emerging Skeletal Risks While GLP-1 receptor agonists such as semaglutide and tirzepatide remain dominant...
Join the mailing list
Be the first to know when fresh articles are published.